ALLMedicine™ Spasmodic Dysphonia Center

May 13th, 2022 - Spasmodic dysphonia (SD) is a focal dystonia affecting the neural control of the laryngeal musculature for speech production. Although the clinical symptoms of SD have been described, the underlying pathological mechanisms remain unknown. Treatmen...

May 7th, 2022 - This systematic review aims to identify instruments used to evaluate treatment outcomes for people with spasmodic dysphonia. Electronic database (PubMed, Cochrane Library, Embase, and CINAHL) searches and hand-searching identified studies that eva...

Mar 20th, 2022 - Adductor spasmodic dysphonia (AdSD) is a neurogenic voice disorder, affecting the intrinsic laryngeal muscle control. AdSD leads to involuntary laryngeal spasms and only reveals during connected speech. Laryngeal high-speed videoendoscopy (HSV) co...

Jan 31st, 2022 - Adductor spasmodic dysphonia (AdSD) is caused by hyperadduction of the vocal folds during phonation, resulting in a strained voice. Animal models are not yet used to elucidate this intractable disease because AdSD has a difficult pathology without...

Dec 1st, 2021 - Methods & Experimental Design: This study will combine a Phase 2 randomized clinical trial to assess the benefits of DBS therapy on SD with a neuroimaging study designed to elucidate the neural pathways for speech. The Surgical Study & Timelines: ...

Mar 2nd, 2018 - Objective This guideline provides evidence-based recommendations on treating patients who present with dysphonia, which is characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication and/or quality of life. ...

May 13th, 2022 - Spasmodic dysphonia (SD) is a focal dystonia affecting the neural control of the laryngeal musculature for speech production. Although the clinical symptoms of SD have been described, the underlying pathological mechanisms remain unknown. Treatmen...

Dec 1st, 2021 - Methods & Experimental Design: This study will combine a Phase 2 randomized clinical trial to assess the benefits of DBS therapy on SD with a neuroimaging study designed to elucidate the neural pathways for speech. The Surgical Study & Timelines: ...

Oct 7th, 2021 - This study is a drug use investigation program of BOTOX. The objective of this investigation is to collect and assess information on the safety and efficacy of BOTOX injections in subjects with a diagnosis of spasmodic dysphonia in daily clinical ...

Oct 1st, 2020 - Focal dystonia is a neurological movement disorder characterized by excessive involuntary muscle contractions of any body part. Spasmodic dysphonia (SD) is a type of focal dystonia characterized by excessive contraction of intrinsic muscles in the...

Aug 16th, 2018 - This study will compare the effects of vocal rest versus continuous vocalization for one hour immediately following botulinum toxin injections for adductor spasmodic dysphonia.

May 24th, 2017 - Cynthia L. Comella, MD [[{"attributes":{},"fields":{}}]] MIAMI—Botulinum toxin injection is the first-line treatment for most focal dystonias.

Nov 1st, 2015 - Botulinum toxin is commonly used to treat movement disorders of the head and neck. It was first used to treat focal eye dystonia (blepharospasm) and laryngeal dystonia (spasmodic dysphonia) and is now also used for other head and neck dystonias, m.

Sep 1st, 2009 - Action Points Note that the American Academy of Otolaryngology -- Head and Neck Surgery has issued its first ever set of guidelines for treatment of dysphonia, or hoarseness. Clinicians should tell patients diagnosed with dysphonia, or hoarseness,...